Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
life sciences
national blog main
11
×
san francisco blog main
san francisco top stories
11
×
clinical trials
new york blog main
new york top stories
boston blog main
boston top stories
national top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
cancer
cancer immunotherapy
deals
fda
investing
medical device
startups
johnson & johnson
medicare
merck
migraine
What
companies
11
×
bio
drug
ipo
life
roundup
science
week
new
biotech
street
wall
approval
days
fda
hasn’t
haul
ipos
latest
leading
led
migraine
momentum
nash
news
price
public
raised
satsuma
slowed
springworks
therapeutics
therapies
welcomed
year
abandoning
activity
ago
alzheimer’s
approved
Language
unset
Current search:
biotech
×
companies
×
" national blog main "
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M